Versant Venture Management
Latest statistics and disclosures from Versant Venture Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GLUE, IPSC, JBIO, LENZ, CTNM, and represent 93.97% of Versant Venture Management's stock portfolio.
- Reduced shares in these 1 stock: JBIO (-$12M).
- Versant Venture Management was a net seller of stock by $-12M.
- Versant Venture Management has $163M in assets under management (AUM), dropping by 14.99%.
- Central Index Key (CIK): 0001560009
Tip: Access up to 7 years of quarterly data
Positions held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Common Stock (GLUE) | 47.3 | $77M | 3.2M | 24.20 |
|
|
| Century Therapeutics Common Stock (IPSC) | 18.3 | $30M | 12M | 2.45 |
|
|
| Jade Biosciences Common Stock (JBIO) | 13.6 | $22M | -35% | 992k | 22.22 |
|
| Lenz Therapeutics Common Stock (LENZ) | 9.3 | $15M | 2.7M | 5.68 |
|
|
| Contineum Therapeutics Common Stock (CTNM) | 5.5 | $8.9M | 543k | 16.39 |
|
|
| CRISPR Therapeutics Common Shares (CRSP) | 5.0 | $8.1M | 149k | 54.54 |
|
|
| Skye Bioscience Common Stock (SKYE) | 0.9 | $1.4M | 2.0M | 0.69 |
|
|
| Tempest Therapeutics Common Stock | 0.2 | $299k | 270k | 1.11 |
|
Past Filings by Versant Venture Management
SEC 13F filings are viewable for Versant Venture Management going back to 2014
- Versant Venture Management 2026 Q2 filed Aug. 12, 2026
- Versant Venture Management 2026 Q1 filed May 5, 2026
- Versant Venture Management 2025 Q4 filed Feb. 12, 2026
- Versant Venture Management 2025 Q3 filed Nov. 10, 2025
- Versant Venture Management 2025 Q2 filed Aug. 11, 2025
- Versant Venture Management 2025 Q1 filed May 7, 2025
- Versant Venture Management 2024 Q4 filed Feb. 12, 2025
- Versant Venture Management 2024 Q3 filed Nov. 8, 2024
- Versant Venture Management 2024 Q2 filed Aug. 7, 2024
- Versant Venture Management 2024 Q1 filed May 3, 2024
- Versant Venture Management 2023 Q4 filed Feb. 8, 2024
- Versant Venture Management 2023 Q3 filed Nov. 3, 2023
- Versant Venture Management 2023 Q2 filed Aug. 9, 2023
- Versant Venture Management 2023 Q1 filed May 11, 2023
- Versant Venture Management 2022 Q4 filed Feb. 9, 2023
- Versant Venture Management 2022 Q3 filed Nov. 10, 2022